Bank Of New York Mellon Corp Immunity Bio, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.35 - $4.78 $594,449 - $2.1 Million	440,333 New	440,333 $801 Million
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $1.96 Million - $3.05 Million	449,949 New	449,949 $2.28 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $303,461 - $534,590	83,140 Added 23.2%	441,498 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $41,754 - $95,661	15,580 Added 4.55%	358,358 $1.33 Million
Q1 2022 May 11, 2022	SELL	$5.05 - $7.53 $57,782 - $86,158	-11,442 Reduced 3.23%	342,778 $1.92 Million
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $14,968 - $26,875	2,640 Added 0.75%	354,220 $2.15 Million
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $380,839 - $591,401	41,531 Added 13.39%	351,580 $3.42 Million
Q2 2021 Aug 11, 2021	BUY	$13.41 - $22.4 $1.92 Million - $3.21 Million	143,202 Added 85.83%	310,049 $4.43 Million
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $2.14 Million - $7.05 Million	166,847 New	166,847 $3.96 Million

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.07B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.